“BBIL is confident about obtaining WHO EUL subsequently, given its experience of getting its other vaccines prequalified by WHO,” said ANI citing sources. WHO developed the process of listing vaccines for emergency use to help deal with public health emergencies similar to the Covid-19 pandemic. Bharat Biotech held a meeting with government officials to discuss the EUL listing of Covaxin, sources told agencies. The manufacturer conveyed to the government that 90% of the required documents asked for by WHO for emergency listing has already been handed over and the rest will be submitted in June. Individuals inoculated with both Covaxin and Russia’s Sputnik V may not be allowed to travel as WHO is yet to include either in its emergency use listing.

Source: Hindustan Times May 24, 2021 15:10 UTC